5-72107706-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4_ModerateBP6BS2
The ENST00000296755.12(MAP1B):āc.175A>Gā(p.Ile59Val) variant causes a missense change. The variant allele was found at a frequency of 0.000409 in 1,599,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I59T) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000296755.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP1B | NM_005909.5 | c.175A>G | p.Ile59Val | missense_variant | 1/7 | ENST00000296755.12 | NP_005900.2 | |
LOC105379028 | XR_001742727.3 | n.4713+1069T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP1B | ENST00000296755.12 | c.175A>G | p.Ile59Val | missense_variant | 1/7 | 1 | NM_005909.5 | ENSP00000296755 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152030Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000215 AC: 51AN: 236708Hom.: 0 AF XY: 0.000200 AC XY: 26AN XY: 129738
GnomAD4 exome AF: 0.000429 AC: 621AN: 1447158Hom.: 0 Cov.: 32 AF XY: 0.000412 AC XY: 297AN XY: 720506
GnomAD4 genome AF: 0.000217 AC: 33AN: 152030Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74262
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at